Jim Cramer says stocks are caught between the forces of inflation and deflation, and investors need to find companies that can adapt.

Medical device maker doubling down on heart valve research, CEO Michael Mussallem tells Cramer.

Jim Cramer reminds us the Dow has soared from 1,000 to 35,000 over the course of his career. That's quite a run, despite all the investor negativity.

Jim Cramer’s bullish on Snap, Boston Scientific and Cleveland-Cliffs.

Jim Cramer says the FAANG stocks get the benefit of the doubt, and they deserve it.

Edwards Lifesciences said its sees transcatheter aortic valve replacement (TAVR) sales rising as high as 20% this year.

Jim Cramers sifts through this relentless run in the reopening plays to find the less-obvious companies poised for profit.

Despite the IPO euphoria, the backdrop to this market is just too optimistic to bet against the bulls, Jim Cramer says.

Jim Cramer says the markets are optimistic about a vaccine, but he cautions there’s a long way to go. We still need more stimulus.

Apple is asking assemblers to put together 220 million iPhones this year, Bloomberg reported, a tally that largely matches 2021 levels.

Electric-truck manufacturer Nikola, like the broad vehicle industry, has been struggling with supply-chain issues.

DNA-sequencing leader Illumina swung to a loss in Q2 2022. Contributions from Grail didn't help.